UNITED THERAPEUTICS CORP (UTHR) Stock News
NASDAQ:UTHR - Nasdaq - US91307C1027 - Common Stock - Currency: USD
UTHR Latest News, Press Relases and Analysis
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - A Strong Candidate for GARP Investors
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) offers strong growth, profitability, and a cheap valuation, making it a standout for GARP investors following Peter Lynch's strategy.
Examining the Quality Attributes of UNITED THERAPEUTICS CORP (NASDAQ:UTHR).
A fundamental analysis of (NASDAQ:UTHR): Why UNITED THERAPEUTICS CORP (NASDAQ:UTHR) qualifies as a quality stock.
Liquidia Scores FDA Nod For Lung Disease Drug Yutrepia, Faces Legal Challenge
Liquidia gains FDA approval for Yutrepia to treat PAH and PH-ILD, with funding in place despite ongoing patent litigation with United Therapeutics
Mentions: LQDA
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers.
Mentions: MYGN
1 Safe-and-Steady Stock on Our Buy List and 2 to Ignore
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Is United Therapeutics (UTHR) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?
We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other best stocks to buy according to Jim Simons’ Renaissance Technologies. Even after his passing in 2024, billionaire investor and […]
The Top 3 Stock Picks at the World’s Greatest Hedge Fund
See which three stocks the world's most successful hedge fund, which generated returns of +30% for decades, had the biggest stakes in at the end of 2024.
United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for United Therapeutics (UTHR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
United Therapeutics Corporation Reports First Quarter 2025 Financial Results
Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?
Neurocrine (NBIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: NBIX
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference
United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025
Dave Ramsey Reveals One Trait Among Successful Financial Transformations: 'Few People Have The Courage To Seek Out Change'
Financial guru Dave Ramsey has helped many people with his bestselling books and "The Ramsey Show." However, you can also get valuable insights from Ramsey by looking at his X feed. He recently put out an X post saying, "Change is painful. Few people have the courage to seek out change." While seeking change is intimidating for many people, it may be the exact shift you need to transform your finances. Don't Miss: Hasbro, MGM, and Skechers trust this AI marketing firm — invest pre-IPO from $0.55
United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work
Is United Therapeutics Corporation (UTHR) The Most Profitable Biotech Stock To Buy Right Now?
We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most profitable biotech stocks to buy right now. With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry […]
Is Domino’s Pizza (DPZ) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where Domino’s Pizza, Inc. (NASDAQ:DPZ) stands against other most expensive stocks insiders are dumping in March. After being in the green for a few trading sessions, the broader market […]
Is FactSet Research Systems (FDS) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where FactSet Research Systems Inc. (NYSE:FDS) stands against other most expensive stocks insiders are dumping in March. After being in the green for a few trading sessions, the broader […]
Is Enstar Group (ESGR) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where Enstar Group Limited (NASDAQ:ESGR) stands against other most expensive stocks insiders are dumping in March. After being in the green for a few trading sessions, the broader market […]